• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小于 24 月龄儿童因呼吸道合胞病毒导致的住院治疗。

Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age.

机构信息

Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.

出版信息

Pediatrics. 2013 Aug;132(2):e341-8. doi: 10.1542/peds.2013-0303. Epub 2013 Jul 22.

DOI:10.1542/peds.2013-0303
PMID:23878043
Abstract

BACKGROUND

Respiratory syncytial virus (RSV) infection is a leading cause of hospitalization among infants. However, estimates of the RSV hospitalization burden have varied, and precision has been limited by the use of age strata grouped in blocks of 6 to ≥ 12 months.

METHODS

We analyzed data from a 5-year, prospective, population-based surveillance for young children who were hospitalized with laboratory-confirmed (reverse-transcriptase polymerase chain reaction) RSV acute respiratory illness (ARI) during October through March 2000-2005. The total population at risk was stratified by month of age by birth certificate information to yield hospitalization rates.

RESULTS

There were 559 (26%) RSV-infected children among the 2149 enrolled children hospitalized with ARI (85% of all eligible children with ARI). The average RSV hospitalization rate was 5.2 per 1000 children <24 months old. The highest age-specific rate was in infants 1 month old (25.9 per 1000 children). Infants ≤ 2 months of age, who comprised 44% of RSV-hospitalized children, had a hospitalization rate of 17.9 per 1000 children. Most children (79%) were previously healthy. Very preterm infants (<30 weeks' gestation) accounted for only 3% of RSV cases but had RSV hospitalization rates 3 times that of term infants.

CONCLUSIONS

Young infants, especially those who were 1 month old, were at greatest risk of RSV hospitalization. Four-fifths of RSV-hospitalized infants were previously healthy. To substantially reduce the burden of RSV hospitalizations, effective general preventive strategies will be required for all young infants, not just those with risk factors.

摘要

背景

呼吸道合胞病毒(RSV)感染是导致婴儿住院的主要原因。然而,RSV 住院负担的估计值各不相同,由于使用了以 6 个月为间隔分组的年龄层,其精确性受到限制。

方法

我们分析了 2000 年 10 月至 2005 年 3 月期间,一项针对因实验室确诊(逆转录聚合酶链反应)RSV 急性呼吸道感染(ARI)住院的幼儿进行的为期 5 年、前瞻性、基于人群的监测数据。根据出生证明信息,按月龄对总风险人群进行分层,以得出住院率。

结果

在因 ARI 住院的 2149 名登记儿童中,有 559 名(26%)为 RSV 感染儿童(所有合格的 ARI 儿童中有 85%)。24 个月以下儿童的平均 RSV 住院率为每 1000 名儿童 5.2 例。特定年龄的最高发病率是 1 个月大的婴儿(每 1000 名儿童 25.9 例)。2 个月以下的婴儿(占 RSV 住院儿童的 44%)住院率为每 1000 名儿童 17.9 例。大多数儿童(79%)既往健康。极早产儿(<30 周)仅占 RSV 病例的 3%,但 RSV 住院率是足月婴儿的 3 倍。

结论

小婴儿,尤其是 1 个月大的婴儿,患 RSV 住院的风险最高。五分之四的 RSV 住院婴儿既往健康。为了大幅降低 RSV 住院负担,需要针对所有小婴儿,而不仅仅是有危险因素的婴儿,制定有效的一般性预防策略。

相似文献

1
Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age.小于 24 月龄儿童因呼吸道合胞病毒导致的住院治疗。
Pediatrics. 2013 Aug;132(2):e341-8. doi: 10.1542/peds.2013-0303. Epub 2013 Jul 22.
2
Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children.基于人群的幼儿呼吸道合胞病毒、流感病毒和副流感病毒相关住院监测。
Pediatrics. 2004 Jun;113(6):1758-64. doi: 10.1542/peds.113.6.1758.
3
Evaluation of case definitions for estimation of respiratory syncytial virus associated hospitalizations among children in a rural community of northern India.印度北部一个农村社区儿童呼吸道合胞病毒相关住院病例定义评估,用于估计住院情况。
J Glob Health. 2015 Dec;5(2):010419. doi: 10.7189/jogh.05.020419.
4
Respiratory syncytial virus infection in Guatemala, 2007-2012.2007-2012 年危地马拉呼吸道合胞病毒感染。
J Infect Dis. 2013 Dec 15;208 Suppl 3:S197-206. doi: 10.1093/infdis/jit517.
5
Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.在住院率高且季节延长的地区,呼吸道合胞病毒住院人数下降。
Pediatr Infect Dis J. 2006 Dec;25(12):1116-22. doi: 10.1097/01.inf.0000245104.26996.57.
6
Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.呼吸道合胞病毒感染对足月儿和早产儿住院治疗的结局及费用影响
J Perinatol. 2016 Nov;36(11):990-996. doi: 10.1038/jp.2016.113. Epub 2016 Aug 4.
7
Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016.呼吸道合胞病毒相关的幼儿住院治疗:2015-2016 年。
Pediatrics. 2020 Jul;146(1). doi: 10.1542/peds.2019-3611. Epub 2020 Jun 16.
8
Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis.呼吸道合胞病毒与孕32周或更早出生的早产儿:预防的住院治疗及经济影响
Arch Pediatr Adolesc Med. 2000 Jan;154(1):55-61.
9
The burden of respiratory syncytial virus infection in young children.幼儿呼吸道合胞病毒感染的负担
N Engl J Med. 2009 Feb 5;360(6):588-98. doi: 10.1056/NEJMoa0804877.
10
Appropriateness of age thresholds for respiratory syncytial virus immunoprophylaxis in moderate-preterm infants: a cohort study.中度早产儿应用呼吸道合胞病毒免疫预防的年龄阈值适宜性:一项队列研究。
JAMA Pediatr. 2013 Dec;167(12):1118-24. doi: 10.1001/jamapediatrics.2013.2636.

引用本文的文献

1
Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025.2025年美国免疫实践咨询委员会关于使用克来罗韦单抗预防婴儿严重呼吸道合胞病毒相关下呼吸道感染的建议
MMWR Morb Mortal Wkly Rep. 2025 Aug 28;74(32):508-514. doi: 10.15585/mmwr.mm7432a3.
2
Young infants with bronchiolitis at low risk of respiratory deterioration in an urban, academic emergency department: prospective cohort study protocol.城市学术急诊科中呼吸恶化风险较低的毛细支气管炎婴幼儿:前瞻性队列研究方案
BMJ Open. 2025 Aug 26;15(8):e101880. doi: 10.1136/bmjopen-2025-101880.
3
Burden of respiratory syncytial virus disease in infants and the potential value of maternal immunization in Greece.
希腊婴儿呼吸道合胞病毒疾病负担及母体免疫的潜在价值。
Front Public Health. 2025 Jul 16;13:1611483. doi: 10.3389/fpubh.2025.1611483. eCollection 2025.
4
The impact of nirsevimab prophylaxis on RSV hospitalizations: a real-world cost-benefit analysis in Tuscany, Italy.尼塞韦单抗预防对呼吸道合胞病毒住院治疗的影响:意大利托斯卡纳的一项真实世界成本效益分析
Front Public Health. 2025 Jul 3;13:1604331. doi: 10.3389/fpubh.2025.1604331. eCollection 2025.
5
Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025.呼吸道合胞病毒预防产品引入后美国婴幼儿呼吸道合胞病毒住院率的中期评估——2024年10月至2025年2月
MMWR Morb Mortal Wkly Rep. 2025 May 8;74(16):273-281. doi: 10.15585/mmwr.mm7416a1.
6
Respiratory syncytial virus glycoprotein G impedes CXCR1-activation by CXCL1 and monocyte function.呼吸道合胞病毒糖蛋白G通过CXCL1阻碍CXCR1激活和单核细胞功能。
Npj Viruses. 2024 Dec 5;2(1):63. doi: 10.1038/s44298-024-00075-9.
7
Global Pediatric Pulmonology Alliance recommendations to protect all infants against respiratory syncytial virus with prophylactic monoclonal antibodies.全球儿科肺病联盟关于使用预防性单克隆抗体保护所有婴儿免受呼吸道合胞病毒感染的建议。
Pediatr Investig. 2025 Feb 11;9(1):35-40. doi: 10.1002/ped4.12465. eCollection 2025 Mar.
8
Using Multiple Methods to Estimate Respiratory Syncytial Virus (RSV)-associated Hospitalization Rates in Children Aged < 5 Years-Hamilton County, Ohio, 2009-2017.运用多种方法估算2009 - 2017年俄亥俄州汉密尔顿县5岁以下儿童呼吸道合胞病毒(RSV)相关住院率
Influenza Other Respir Viruses. 2025 Apr;19(4):e70096. doi: 10.1111/irv.70096.
9
Health economic evaluation of implementing a universal immunization program with nirsevimab compared to standard of care for the prevention of respiratory syncytial virus disease in Canadian infants.与加拿大婴儿预防呼吸道合胞病毒疾病的标准治疗相比,实施含nirsevimab的通用免疫计划的卫生经济评估。
Hum Vaccin Immunother. 2025 Dec;21(1):2480875. doi: 10.1080/21645515.2025.2480875. Epub 2025 Apr 5.
10
Cost-Effectiveness and Public Health Impact of Universal Prophylaxis with Nirsevimab Against Respiratory Syncytial Virus (RSV) Infections in all Infants in Japan.在日本对所有婴儿使用尼塞韦单抗进行呼吸道合胞病毒(RSV)感染普遍预防的成本效益和公共卫生影响
Infect Dis Ther. 2025 Apr;14(4):847-865. doi: 10.1007/s40121-025-01134-1. Epub 2025 Mar 28.